France has taken a significant regulatory step by releasing detailed implementation rules for its national ban on per- and polyfluoroalkyl substances (PFAS) in consumer products. The new provisions, set out in Decree No. 2025-1376, operationalize the broader framework established by Law No. 2025-188, adopted in February 2025, and effective from 1 January 2026.
The decree clarifies the scope, thresholds, and exemptions applicable to the ban, transforming a political commitment into enforceable obligations. PFAS—often referred to as “forever chemicals” due to their persistence in the environment—are now prohibited in several categories of consumer goods, including cosmetics, textiles, footwear, and ski waxes, where safer alternatives exist.
A key feature of the implementation rules is the introduction of residual concentration limits. Rather than imposing a zero-tolerance approach, the regulation allows trace levels of PFAS below defined thresholds, acknowledging the technical challenges of complete elimination in complex supply chains.
The decree also establishes targeted exemptions. These include certain essential uses such as personal protective equipment and specific industrial applications where substitution is not yet feasible. In addition, transitional provisions permit products manufactured before 1 January 2026 to remain on the market for a limited period, typically until 2027, easing the economic impact on manufacturers and distributors.
Importantly, the French approach adopts a conditional ban: products containing PFAS are prohibited only where viable alternatives are available. This introduces a dynamic compliance requirement, pushing industry toward innovation while avoiding disproportionate disruption.
France’s initiative positions the country as a regulatory frontrunner within the European Union, anticipating broader restrictions currently under discussion at EU level. By defining technical criteria such as thresholds and exemptions, the implementation rules provide a practical template for future harmonized legislation.
Overall, the decree marks a critical transition from legislative intent to regulatory enforcement, reinforcing France’s commitment to reducing environmental and human exposure to PFAS while balancing industrial feasibility.
